TPD52L3

gene
On this page

Also known as NYD-SP25D55TPD55

Summary

TPD52L3 (TPD52 like 3, HGNC:23382) is a protein-coding gene on chromosome 9p24.1, encoding Tumor protein D55 (Q96J77).

This gene encodes a member of the tumor protein D52-like family of proteins. These proteins are characterized by an N-terminal coiled-coil motif that is used to form homo- and heteromeric complexes with other tumor protein D52-like proteins. The encoded protein may play a role in spermatogenesis. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 89882 — RefSeq curated summary.

At a glance

  • GWAS associations: 16
  • Clinical variants (ClinVar): 26 total
  • MANE Select transcript: NM_001001874

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23382
Approved symbolTPD52L3
NameTPD52 like 3
Location9p24.1
Locus typegene with protein product
StatusApproved
AliasesNYD-SP25, D55, TPD55
Ensembl geneENSG00000170777
Ensembl biotypeprotein_coding
OMIM617567
Entrez89882

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000314556, ENST00000344545, ENST00000381428

RefSeq mRNA: 3 — MANE Select: NM_001001874 NM_001001874, NM_001001875, NM_033516

CCDS: CCDS34984, CCDS34985, CCDS34986

Canonical transcript exons

ENST00000314556 — 2 exons

ExonStartEnd
ENSE0000116514363283756328962
ENSE0000127276963309766331891

Expression profiles

Bgee: expression breadth broad, 36 present calls, max score 98.92.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5074 / max 480.4055, expressed in 6 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
959870.43465
959860.07284

Top tissues by expression

172 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001998.92gold quality
left testisUBERON:000453396.90gold quality
right testisUBERON:000453496.72gold quality
testisUBERON:000047394.23gold quality
adult organismUBERON:000702392.36gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.05gold quality
kidney epitheliumUBERON:000481987.14gold quality
upper arm skinUBERON:000426383.66gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451181.33gold quality
nasal cavity epitheliumUBERON:000538480.35gold quality
parotid glandUBERON:000183178.72gold quality
cardiac muscle of right atriumUBERON:000337978.27gold quality
myocardiumUBERON:000234978.21gold quality
epithelial cell of pancreasCL:000008377.91gold quality
left ventricle myocardiumUBERON:000656677.82gold quality
vastus lateralisUBERON:000137976.67gold quality
vena cavaUBERON:000408775.80gold quality
quadriceps femorisUBERON:000137775.02gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450273.69gold quality
body of tongueUBERON:001187673.37gold quality
tongueUBERON:000172371.68gold quality
ponsUBERON:000098871.60silver quality
inferior vagus X ganglionUBERON:000536371.37gold quality
cardia of stomachUBERON:000116271.04gold quality
nippleUBERON:000203070.79gold quality
superior surface of tongueUBERON:000737170.73gold quality
pylorusUBERON:000116670.72gold quality
tracheaUBERON:000312670.65gold quality
substantia nigra pars reticulataUBERON:000196670.63silver quality
pericardiumUBERON:000240770.59gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.79

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

101 targeting TPD52L3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4533100.0069.482758
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4425100.0067.591049
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4283100.0066.422097
HSA-MIR-34A-5P99.9971.211784
HSA-MIR-449A99.9971.051776
HSA-MIR-520G-5P99.9966.76658
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-548AW99.9972.573559
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-34C-5P99.9770.451577
HSA-MIR-449B-5P99.9770.261580
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-570-3P99.9672.414910
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-211099.9666.681930
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusTrpd52l3ENSMUSG00000024815
rattus_norvegicusTpd52l3ENSRNOG00000042441
drosophila_melanogasterCG5174FBGN0034345
caenorhabditis_elegansWBGENE00008745

Paralogs (3): TPD52 (ENSG00000076554), TPD52L2 (ENSG00000101150), TPD52L1 (ENSG00000111907)

Protein

Protein identifiers

Tumor protein D55Q96J77 (reviewed: Q96J77)

Alternative names: Testis development protein NYD-SP25, Tumor protein D52-like 3

All UniProt accessions (1): Q96J77

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Interacts with TPD52L2.

Tissue specificity. Specifically expressed in testis. Expressed at 5.6-fold higher levels in adult testis than in fetal testis.

Similarity. Belongs to the TPD52 family.

Isoforms (3)

UniProt IDNamesCanonical?
Q96J77-11yes
Q96J77-22
Q96J77-33

RefSeq proteins (3): NP_001001874, NP_001001875, NP_277051 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007327TPD52Family

Pfam: PF04201

UniProt features (8 total): splice variant 2, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96J77-F173.000.20

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 36 (showing top): FXR_IR1_Q6, FOXO4_01, FOXO1_01, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, AKT_UP_MTOR_DN.V1_UP, AKT_UP.V1_UP, ESC_J1_UP_EARLY.V1_DN, NFKBIA_TARGET_GENES, MIR570_3P, MIR5688, MIR495_3P, MIR1468_3P, MIR3065_5P, MIR1283

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

268 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TPD52L3PDIK1LQ8N165453
TPD52L3SPACA7Q96KW9444
TPD52L3CCDC89Q8N998393
TPD52L3CIMIP4O43247375
TPD52L3CFAP276Q5T5A4359
TPD52L3MEMO1Q9Y316334
TPD52L3ITIH2P19823327
TPD52L3MFSD6LQ8IWD5326
TPD52L3PAFAH1B2P68402322
TPD52L3MTMR2Q13614319
TPD52L3IFT74Q96LB3318
TPD52L3EIF3HO15372312
TPD52L3FNDC8Q8TC99289
TPD52L3WDR47O94967284
TPD52L3CATSPERZQ9NTU4275

IntAct

20 interactions, top by confidence:

ABTypeScore
AGTRAPTPD52L3psi-mi:“MI:0915”(physical association)0.560
CMTM5TPD52L3psi-mi:“MI:0915”(physical association)0.560
TPD52L3AGTRAPpsi-mi:“MI:0915”(physical association)0.560
TPD52L3TPD52L2psi-mi:“MI:0914”(association)0.530
TPD52L3TPD52L2psi-mi:“MI:0407”(direct interaction)0.440
TPD52L2TPD52L3psi-mi:“MI:0407”(direct interaction)0.440
TPD52L3H3-4psi-mi:“MI:0915”(physical association)0.400
TPD52L3H2BC21psi-mi:“MI:0915”(physical association)0.400
TPD52L3H1-5psi-mi:“MI:0915”(physical association)0.400
NFICTPD52L3psi-mi:“MI:0915”(physical association)0.370
TPD52TPD52L3psi-mi:“MI:0915”(physical association)0.000
TPD52L1TPD52L3psi-mi:“MI:0915”(physical association)0.000
TPD52L3TPD52L3psi-mi:“MI:0915”(physical association)0.000
TPD52L3DKFZp686A1765psi-mi:“MI:0915”(physical association)0.000

BioGRID (18): TPD52L3 (Two-hybrid), CMTM5 (Two-hybrid), TPD52L3 (Two-hybrid), TPD52L3 (Two-hybrid), TPD52L3 (Proximity Label-MS), TPD52L3 (Proximity Label-MS), TPD52L3 (Proximity Label-MS), TPD52L3 (Two-hybrid), TPD52L3 (Two-hybrid), GABPB1 (Affinity Capture-MS), GABPA (Affinity Capture-MS), TPD52 (Affinity Capture-MS), TPD52L1 (Affinity Capture-MS), TPD52L2 (Affinity Capture-MS), MYO18A (Affinity Capture-MS)

ESM2 similar proteins: A0A1L1SUL6, A1A4P9, A6NJR5, A6NNV3, A7VL23, B2RXH8, B7ZW38, D4A693, K7N6K2, O54818, O70593, O95568, P0CW24, P0DMR1, P0DV79, P51878, P55327, Q06GP8, Q16890, Q1ACD6, Q1ACD7, Q2HJ93, Q2M2D7, Q2YEM8, Q3KPR1, Q3SZ27, Q49AS3, Q4AC99, Q52LC2, Q5D7H7, Q5D7I1, Q5NVS6, Q5R387, Q62393, Q6EIX2, Q6UXV4, Q7YRC0, Q864V5, Q86UD7, Q8BJU0

Diamond homologs: O43399, O54818, P55326, P55327, Q16890, Q5RCT1, Q62393, Q6PCT3, Q95212, Q96J77, Q9CYZ2, Q9I8F4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

26 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

199 predictions. Top by Δscore:

VariantEffectΔscore
9:6328983:TCCA:Tdonor_gain0.9700
9:6328916:G:GTdonor_gain0.9200
9:6329726:T:TAdonor_gain0.9000
9:6329727:A:AAdonor_gain0.9000
9:6328996:G:GTdonor_gain0.8800
9:6328930:TGAAG:Tdonor_gain0.7500
9:6328934:G:GTdonor_gain0.7500
9:6329192:C:CGdonor_gain0.6800
9:6330323:A:AGacceptor_gain0.6600
9:6329187:T:Adonor_gain0.5900
9:6329273:AAGTG:Adonor_gain0.5800
9:6329180:C:Gdonor_gain0.5700
9:6329724:G:GAdonor_gain0.5700
9:6330176:TTTTA:Tacceptor_loss0.5700
9:6330177:TTTAG:Tacceptor_loss0.5700
9:6330178:TTAGG:Tacceptor_loss0.5700
9:6330179:TA:Tacceptor_loss0.5700
9:6330180:A:Cacceptor_loss0.5700
9:6330181:G:GAacceptor_loss0.5700
9:6330324:A:Gacceptor_gain0.5600
9:6329179:A:AGdonor_gain0.5200
9:6330153:CTTAA:Cacceptor_loss0.5200
9:6330156:A:AGacceptor_loss0.5200
9:6330167:T:TAacceptor_loss0.5200
9:6330154:TTAAC:Tacceptor_loss0.5100
9:6330155:TAACT:Tacceptor_loss0.5100
9:6330171:CTTCT:Cacceptor_loss0.5100
9:6330172:TTCTT:Tacceptor_loss0.5100
9:6330173:TCTTT:Tacceptor_loss0.5100
9:6330180:A:AGacceptor_gain0.5100

AlphaMissense

865 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:6328778:G:CK61N0.696
9:6328778:G:TK61N0.696
9:6328947:T:CF118L0.691
9:6328949:C:AF118L0.691
9:6328949:C:GF118L0.691
9:6328753:A:TK53I0.667
9:6328754:A:CK53N0.623
9:6328754:A:TK53N0.623
9:6328934:G:CK113N0.581
9:6328934:G:TK113N0.581
9:6328735:G:CR47P0.580

dbSNP variants (sampled 300 via entrez): RS1000132401 (9:6332300 G>A), RS1000784367 (9:6330011 A>T), RS1001062293 (9:6326397 G>C), RS1001353391 (9:6331431 T>C), RS1002009368 (9:6329018 ACTGT>A), RS1003163871 (9:6327284 G>A), RS1003448805 (9:6328024 T>C), RS1004464017 (9:6330527 G>C), RS1004736804 (9:6326591 A>G), RS1004756831 (9:6330832 C>A,G), RS1005350510 (9:6329503 A>G), RS1005572895 (9:6331670 G>C,T), RS1005687187 (9:6331480 G>A,T), RS1005895125 (9:6327348 T>A,C), RS1006857601 (9:6327602 T>G)

Disease associations

OMIM: gene MIM:617567 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

16 associations (top):

StudyTraitp-value
GCST001588_15Periodontal microbiota3.000000e-06
GCST005213_5Asthma (childhood onset)3.000000e-08
GCST007563_32Allergic disease (asthma, hay fever or eczema)4.000000e-08
GCST007564_32Asthma or allergic disease (pleiotropy)4.000000e-22
GCST008916_20Asthma5.000000e-36
GCST008916_26Asthma3.000000e-64
GCST008916_47Asthma2.000000e-08
GCST008916_5Asthma7.000000e-17
GCST008916_83Asthma1.000000e-08
GCST008916_9Asthma4.000000e-18
GCST009391_235Metabolite levels5.000000e-06
GCST009798_28Asthma4.000000e-18
GCST009798_8Asthma5.000000e-67
GCST010083_249Hemoglobin levels3.000000e-09
GCST90002382_270Eosinophil percentage of white cells6.000000e-11
GCST90002403_603Red blood cell count5.000000e-16

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0010493glycodeoxycholate measurement
EFO:0004509hemoglobin measurement
EFO:0007991eosinophil percentage of leukocytes
EFO:0004305erythrocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
perfluorooctanoic acidincreases expression1
perfluorooctane sulfonic acidincreases expression1
perfluoro-n-nonanoic acidincreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Catechinaffects cotreatment, decreases expression1
Estradiolincreases expression1
Fenfluramineincreases expression1
Malathiondecreases expression1
Silicon Dioxidedecreases expression1
Antirheumatic Agentsincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): periodontitis